TOP TIERMARKET NEWSWIRE
News & sentiment

VERA THERAPEUTICS IN A (VERA) — News & AI sentiment

VERA THERAPEUTICS IN A (VERA) news roundup. 2 stories in the past week, 9 over 30 days. Average 30-day sentiment is 56.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $3.3M — net selling of $3.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 58.5/100
30d stories
9
avg sentiment 56.7/100
Insider net (90d)
$3.3M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

VERA news in the last 24 hours, 7 days, 30 days and 90 days

How much VERA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowVERA storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days258.5/100VERA headlines →
Last 30 days956.7/100VERA headlines →
Last 90 days3856.6/100VERA headlines →

Latest stories on VERA

5d ago
Sep 4
Sep 4
Sep 4
Sep 1
Sep 1
Aug 24
Aug 17
Vera rises after FDA review for kidney disease therapy
Seeking Alpha67 · bullishproduct/pr
Aug 14
Goldman Sachs lowers Vera Therapeutics stock price target to $80
Investing.com Analyst Ratings34 · bearishanalyst
Aug 12
Aug 11
Aug 11
Aug 11
Aug 10
Vera Therapeutics GAAP EPS of -$1.52 beats by $0.04
Seeking Alpha56 · neutralearnings
Aug 10
Vera Therapeutics, Inc. (VERA) files 8-K
SEC 8-K50 · neutralgeneral
Aug 10
Aug 10
Aug 7
Aug 7
Jul 10
Jul 10
Jul 10
Jul 9
Jul 9
Jul 9
Open VERA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →